Randomized controlled trial of daily interruption of sedatives in critically ill children

Carin W M Verlaat1, Ger P Heesen, Nienke J Vet

  • 1Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Paediatric Anaesthesia
|August 29, 2013
PubMed

Insights

Daily interruption of sedatives in critically ill children is feasible and reduces sedative use. This approach leads to earlier extubation and shorter pediatric intensive care unit stays.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Intensive Care Unit Management

Background:

  • Sedation is commonly used in mechanically ventilated children.
  • Prolonged sedation can lead to adverse effects and longer intensive care unit (ICU) stays.

Purpose of the Study:

  • To evaluate the feasibility of daily interruption of sedative medications in critically ill pediatric patients.
  • To assess the impact of daily sedative interruption on sedative consumption, mechanical ventilation duration, and ICU length of stay.

Main Methods:

  • A prospective randomized controlled open-label trial was conducted in a pediatric intensive care unit.
  • 30 mechanically ventilated children (0-12 years) were randomized to daily sedative interruption or standard care.
  • Sedatives were stopped daily and restarted if a COMFORT-behavior score reached ≥17 in the intervention group.

Main Results:

  • The intervention group showed significantly lower midazolam and morphine use compared to the control group.
  • Duration of mechanical ventilation was significantly shorter in the daily interruption group (4 days vs. 9 days).
  • Length of stay in the pediatric intensive care unit was significantly reduced in the intervention group (6 days vs. 10 days).

Conclusions:

  • Daily interruption of sedatives is a feasible strategy in critically ill children.
  • This intervention leads to decreased sedative requirements.
  • Early extubation and shorter pediatric intensive care unit length of stay are associated with daily sedative interruption.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...